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Title: Nutrition support following the American Dietetic Association (ADA) Medical 
Nutrition Therapy protocol for radiation oncology patients improves dietary intake 
compared with standard practice 
Abstract 
Background A randomized controlled trial previously conducted in radiation 
oncology patients demonstrated that nutrition intervention (NI) had a beneficial 
impact on body weight, nutritional status and quality of life compared with standard 
practice (SP) but did not report on dietary intake data. 
Objective To determine the impact of NI compared with SP on dietary intake in 
outpatients receiving radiotherapy. 
Design Prospective, randomized, controlled trial. 
Subjects Sixty consecutive radiation oncology outpatients (51M;9F; age 61.9 yr ± 
14).  
Setting Australian private radiotherapy facility. 
Intervention Patients were randomized to receive either NI (n=29)(nutrition 
counselling following the ADA Medical Nutrition Therapy (MNT) protocol for 
radiation oncology) or SP (general nutrition talk and booklet)(n=31).  
Main outcome measure Dietary intake (protein, kilocalorie, fiber) assessed at 
baseline, 4, 8 and 12 weeks after starting radiotherapy.  
Statistical analyses Repeated measures ANOVA performed on an intention to treat 
basis.  
Results The NI group had a higher mean total kilocalorie (P=0.029) and protein 
intake (P<0.001) compared with the SP group. Mean intake per kilogram of body 
weight for the NI group ranged from 28-31 kcal/kg/day compared with 25-29 
kcal/kg/day for the SP group (P=0.022). The NI group had a higher mean protein 
intake (1.1-1.3g/kg/day) compared with the SP group (1.0-1.1g/kg/day) (P=0.001). 
While the changes in fiber intake between the groups were not significant there was a 
trend in the anticipated direction (P=0.083). 
Conclusions Intensive NI following the ADA MNT protocol results in improved 
dietary intake compared with SP and appears to beneficially impact on nutrition-
related outcomes previously observed in oncology outpatients receiving radiotherapy.  
Application The ADA MNT protocol for radiation oncology is a useful guide to the 
level of nutrition support required.  
 
 
Title: Nutrition support following the American Dietetic Association (ADA) Medical 
Nutrition Therapy protocol for radiation oncology patients improves dietary intake 
compared with standard practice 
Introduction  
In the current health-care climate there is a need to justify resources and demonstrate the 
importance of effective nutrition services. Outcomes research, the gathering of 
information on the effectiveness of standard practice, has emerged as an essential 
process to determine the value of interventions and services rendered through the 
health-care system (1-3). Research should be action-orientated and evaluate the 
outcome of current clinical practice, nutrition interventions or behavior change strategies 
so that the elements of practice which provide positive outcomes can be determined and 
those practices that are ineffective can be phased out or discarded (4).  
 
With this in mind, the American Dietetic Association (ADA) and Morrison Health 
Care worked together to develop protocols, Medical Nutrition Therapy (MNT) across 
the continuum of care which aims to improve patient outcomes and decrease health-
care costs. MNT protocols were developed during a consultative process with experts 
and incorporate professional knowledge and available research (5). These protocols 
clearly define the level, content and frequency of nutrition care that is appropriate for 
particular disease states in typical settings (6). They have the advantage of providing a 
standard protocol which defines the level and frequency of nutritional care but also 
allows for individual tailoring to meet specific requirements of patients. There are 
several MNT protocols for various disease states/conditions including nutritional 
guidelines for radiation oncology. 
 
It has been suggested that adequate nutrition support during radiotherapy can decrease 
the impact of side effects, minimize weight loss, improve quality of life (QoL) and 
help patients to recover from radiotherapy more quickly (7). Although professional 
experience, pilot and descriptive studies agree with these suggestions, there is little 
evidence based on clinical research to support them. It is well known that malnutrition 
occurs frequently in patients with cancer of the head and neck (8) or gastrointestinal 
area (9) and patients receiving radiotherapy are at further risk due to possible side 
effects such as mucositis, taste changes, dysphagia, nausea and diarrhoea (10). 
Malnutrition can lead to negative consequences such as increased risk of infections, 
treatment toxicity and health-care costs, and decreased response to treatment, QoL 
and life expectancy (11-13). However, few studies have demonstrated the benefits of 
dietary counseling following a standard protocol in patients receiving radiotherapy.  
 
A randomized, controlled trial investigating the impact of nutrition intervention (NI) 
following the ADA MNT radiation oncology protocol versus standard practice 
(SP)(general nutrition talk and booklet), on nutrition-related outcomes in outpatients 
receiving radiotherapy to the gastrointestinal or head and neck area was conducted 
previously by our research group (14). Patients receiving NI experienced significantly 
less deterioration in weight (P<0.001), nutritional status (P=0.020) and global QoL 
(P=0.009) compared with those receiving SP during the 12-week trial. Clinically 
significant differences in fat-free mass were observed between the groups (P=0.195). 
We concluded that NI appeared beneficial in terms of minimizing deterioration in 
nutrition-related outcomes and that weight-maintenance may be a more appropriate 
goal of NI in this population (14) The current paper forms part of the same study and 
reports dietary intake data. The aim of this study was to determine the impact of NI 
following the ADA MNT radiation oncology protocol compared with SP on dietary 
intake in ambulatory oncology patients receiving radiotherapy to the gastrointestinal 
or head and neck area. 
 
Methods and subjects 
This trial was approved by the Queensland University of Technology Human 
Research Ethics Committee (reference number: 2039H) and The Wesley Hospital 
Multidisciplinary Ethics committee (reference number: 98/42) and informed consent 
was obtained from all participants. A prospective, randomized, controlled trial was 
conducted in outpatients who received at least 20 fractions of radiotherapy to the 
gastrointestinal or head and neck area at a private Australian radiotherapy facility 
during a 12-month period. Full methods of the randomized, controlled trial are 
described elsewhere (14). 
 
Nutrition intervention (NI) 
The NI group received regular and intensive nutrition counseling by a dietitian using a 
standard protocol, the ADA MNT protocol for radiation oncology (5). The MNT 
protocol provides general guidelines covering the time and frequency of dietetic 
consultations, the type of data to be collected and NI strategies and also allows 
individualization of the NI to meet the specific goals of patients. Dietetic 
consultations were conducted within four days of starting radiotherapy, weekly for six 
weeks and then every two weeks for the remaining six weeks. Telephone reviews 
were conducted between the face-to-face nutrition counseling sessions. Nutrition 
resources such as quick and easy snack ideas and high kilocalorie and protein 
exchange lists were provided when patients were unable to meet dietary 
recommendations (i.e. usually after the first few weeks of radiotherapy when side 
effects were experienced.) The ADA Oncology Nutrition Practice group educational 
handouts to help minimize treatment-related side effects (15) were used when the 
professional field notes recorded that someone had experienced significant side 
effects that negatively impacted on eating. Individually tailored sample meal plans 
and recipe suggestions were also provided when required during the face-to-face 
interviews. High kilocalorie (1kcal/cc) and protein oral liquid nutrition supplements 
were provided free of charge for up to three months if required. Depending on 
requirements and current intake, patients were typically recommended to consume 
two glasses of supplement per day (total of 480ml). A one or two weeks supply of 
supplement was provided during the counselling session by the dietitian. 
 
Standard practice (SP) 
The SP group received the standard practice of the radiotherapy centre (i.e. a general 
nutrition talk by the nurses as part of the planning stages for radiotherapy, a nutrition 
and cancer booklet (16) and high kilocalorie and protein supplement samples.) 
Patients had the option of seeing an outpatient dietitian and received the standard 
practice of that dietitian which was a maximum of two visits. The NI group received 
tailored and more intensive and ongoing nutrition support when compared with the SP 
group who received general advice.  
 
Data collection 
Dietary intake 
Dietary intake was assessed using a modification of the Burke diet history technique 
(17) and measured at baseline, 4, 8 and 12 weeks after starting radiotherapy. Subjects 
were systematically asked about dietary intake during a typical 24-hour period, then 
asked to account for variations (e.g. weekends and take away meals), and finally a 
checklist was used as a cross check on the types and quantities of certain foods 
consumed during the week. Food models were used to help estimate serving sizes. 
Each interview lasted 40-60 minutes. Mean protein, kilocalorie and fiber intake were 
determined using computerised Australian food composition data (Food Works 
Professional, Version 2, 2000, Xyris Software, Brisbane, Australia). Total kilocalorie 
requirements were estimated using the Harris Benedict equation (18) and an activity 
factor of between 1.2-1.5 and a stress factor of 1.2 applied (19). For overweight and 
obese patients an adjusted body weight was calculated as ideal body weight plus 50% 
of the difference between ideal and actual body weight as described by Barak et al 
(19). Underweight patients had an adjusted weight that was equivalent to the lower 
end of the healthy body mass index (BMI) range. Protein requirements were estimated 
using 1.2-1.5g/kg/d. 
 
Nutritional status 
Weight was measured to the nearest 0.1kg (Tanita Inc,. Tokyo, Japan, Model 300GS) 
and height was measured to the nearest 0.1cm with a stadiometer (Harpenden, Holtain 
Ltd, Crosswell, Dyfed, UK) following standard procedures (i.e. without shoes, 
minimal clothing and bringing the stadiometer sliding board onto the vertex with the 
head in the Frankfurt plane.) A trained professional took single measures of height 
and weight. Scales were checked to be appropriately calibrated prior to data collection 
and half-way during the data collection period by Wedderburn Scales (Brisbane, 
Australia). Patients were requested to eat and drink minimally for 2 hours prior to 
assessments. BMI was calculated from current weight and height using the standard 
formula: weight/height2 (kg/m2). 
 
Nutritional status was assessed using the valid and reliable scored Patient Generated-
Subjective Global Assessment (PG-SGA) (13,20) which consists of a patient-
completed section and a physical examination conducted by the trained health 
professional (i.e. dietitian.) Each subject was classified as well nourished (PG-SGA 
A), moderately malnourished or suspected of being malnourished (PG-SGA B), or 
severely malnourished (PG-SGA C), and a numerical PG-SGA score was calculated. 
Typical scores range from 0-35, with a higher score reflecting greater deterioration in 
nutritional status, and scores ≥9 indicating a critical need for nutrition intervention 
and/or symptom management (14,20). The PG-SGA score has been correlated with a 
number of objective parameters (% weight loss, BMI) and measures of morbidity 
(survival, length of stay) and has a high degree of inter-rater reproducibility (21).  
 
Quality of life (QoL) 
European Organization for the Research and Treatment of Cancer QLQ-C30 (version 
3) a validated, cancer-specific QoL tool was used to assess global QoL and was 
completed as described by the authors (22).  This patient-based instrument is 
comprised of 30 items making up five functional scales (physical, role, cognitive, 
social, emotional), and three symptom scales (fatigue, pain and nausea/vomiting), 
global health status and global QoL scales.  QLQ-C30 results are linearly converted to 
a score out of one hundred, with a higher score reflecting a higher QoL.  
 
Statistical analysis 
All continuous variables were normally distributed except for percentage weight loss 
in the past 6 months which was transformed (natural log) to improve distribution. 
Independent t-tests or Mann Whitney tests where appropriate were used to calculate 
the mean change in outcomes and compared by group. Paired t-tests were used to 
assess differences between estimated and actual kilocalorie and protein intakes at 
baseline. Differences between the NI and SP groups over time were assessed using 
repeated measures ANOVA on an intention to treat basis (SPSS version 10, SPSS Inc. 
Chicago, IL, USA). Statistical significance was reported at the conventional P < 0.05 
level (two-tailed).  
 
The primary outcome on which sample size was calculated was nutritional status as 
determined by PG-SGA score (mean change 12.7 units with standard deviation of 4.6 
units). Assuming a clinically significant difference of 5 units or greater in one group 
relative to the other, then complete data would be required on 18 subjects in each 
group to detect this difference with 90% power and the 95% significance level (2-
tailed).  
 
Results  
Subject characteristics 
Sixty of 78 eligible patients consented to the study. Complete data were available on 
54 subjects. Four deaths occurred during the study (2 in NI and 2 in SP groups) and 2 
patients from the NI group declined to continue the study as one was experiencing 
deterioration in condition and did not wish to complete the measurements and the 
other decided to discontinue radiotherapy treatment and the study. There were no 
significant differences in baseline characteristics (age; gender; BMI; nutritional status; 
tumour type; or radiotherapy treatment) between subjects who did or did not agree to 
take part in the study nor in those who did or did not complete the study. According to 
the scored PG-SGA, 35% (n=21) were malnourished (PG-SGA B and C) at baseline. 
The median weight loss of subjects in the previous six months was 2.8% (0-21). The 
majority of subjects were receiving radiotherapy to the head and neck area (88%, 
n=53) and the remaining 12% (n=7) of patients were receiving radiotherapy to the 
gastrointestinal area.  
 
Subject characteristics at baseline are presented in Table 1. There were no significant 
differences between the NI and SP groups and no differences in the level of symptoms 
experienced by the groups as indicated by the nutrition impact symptom section of the 
scored PG-SGA. While there were no significant differences in the number of 
malnourished patients receiving NI or SP, there were more malnourished patients in 
the NI group (n=12) compared with SP group (n=9). There were no significant 
differences between kilocalorie, protein or fiber intakes at baseline between well 
nourished and malnourished patients receiving NI or SP. Therefore data including 
both well nourished and malnourished patients are presented. 
 
In the NI group, 16 subjects regularly consumed high kilocalorie and protein oral 
nutrition supplements (at least two glasses of supplement per day for at least four 
weeks). No NI subjects received enteral or parenteral nutrition. Five subjects in the SP 
group received nutrition counseling from an outpatient dietitian: four subjects received 
one visit; and one subject received two visits. In the SP group, nine subjects were 
regularly consuming high kilocalorie and protein oral nutrition supplements, one 
subject received nasogastric feeding and one subject received a percutaneous 
gastrostomy.  
 
Dietary intake 
There were no significant differences between estimated and actual kilocalorie intake 
at baseline for either the NI or SP group but the actual protein intakes were less than 
recommended (Figure 1). The NI group had significantly higher mean kilocalorie 
(P=0.029) and protein intakes (P<0.001) compared with those receiving SP during the 
12-week study (Table 2). There was a clinically but not statistically significant mean 
increase in kilocalorie intake over the 12 weeks for those receiving NI (M=86 
kcal/day, Standard Error of the Mean (SEM) =90) compared with patients receiving 
SP [M=-177 kcal/day, SEM=112;t(52)=-1.79, P=0.079]. There was a significant mean 
increase in protein intake for NI patients (M=3.5g, SEM=2.9) compared with SP 
patients (-11.8g, SEM 3.1; t(52) = -3.6, P<0.001). Mean kilocalorie intake per kilogram 
of body weight was greater for the NI group and ranged from 28-31 kcal/kg/day 
compared with 25-29 kcal/kg/day for the SP group over the 12-week period 
(P=0.022). Similarly, the NI group had a greater mean protein intake (1.1-
1.3g/kg/day) compared with the SP group (1.0-1.1g/kg/day) (P=0.001). While the 
repeated measures changes in fiber intake between the groups were not significant 
there was a trend in the anticipated direction (P=0.083). There was however a 
significant mean increase in fiber intake over the 12 weeks for the NI group 
(M=2.2g,SEM=1.2) compared with the SP group (M=-1.5, SEM=0.7; t(52)=-2.7, 
P=0.014). 
 
Figure 2 graphs the mean kilocalorie intake and body weight changes over the 12-
week study for the NI and SP groups. At most time points the mean body weight 
parallels the mean kilocalorie intake, except between week 8 and 12. 
 
During treatment more patients in the NI group were assessed as well nourished and 
less were assessed as malnourished according to PG-SGA global rating compared 
with the SP group (Table 3). This was statistically significant at 8 weeks (X2 (1)=5.4, 
P=0.020) and approached significance at 12 weeks (X2(1)=3.4,P=0.065), where the 
proportion of malnourished patients in the SP group remained greater than pre-
treatment levels. The NI group also had a significantly smaller decrease and faster 
recovery in global QoL (P=0.009) and physical function (P=0.012) over time 
compared with the SP group (14). 
 
Discussion 
This study demonstrated that NI following the ADA MNT radiation oncology 
protocol resulted in improved dietary intake and QoL, and less deterioration in 
nutritional status, when compared with SP in ambulatory oncology patients receiving 
radiotherapy to the gastrointestinal or head and neck area. 
 
Malnutrition 
Before commencing radiotherapy to the gastrointestinal or head and neck area, 35% 
of patients were classified as being either moderately or severely malnourished 
according to PG-SGA global classification. Other studies have observed that 50-75% 
of patients were assessed as malnourished when commencing radiotherapy to the head 
and neck area (23,24). The reasons for the lower prevalence of malnutrition in the 
current study may be due to the fact that it was a more heterogenous population 
including patients receiving radiotherapy to the gastrointestinal, as well as head and 
neck area and also to the various definitions of malnutrition used in other studies. 
However, the fact that 35% of patients were malnourished prior to commencing 
radiotherapy is of concern, as it is known that patients receiving radiotherapy 
treatment are at further risk of having their nutritional status compromised due to 
possible side effects which may affect oral intake (10).  
 
Dietary intake  
While both NI and SP groups had comparable kilocalorie and protein intakes at 
baseline, it is evident from Table and Figure 1 that those receiving NI had an increase 
in kilocalorie and protein intake during the first four weeks of treatment and then 
maintained an intake similar to that consumed at baseline over the 12-week study. In 
contrast, those receiving SP had a steady decrease in kilocalorie intake which only 
started to increase at week 12 where it was still 177 kcal/day less than at baseline. 
This change in nutrition intake follows the natural progression in side effects for 
patients receiving radiotherapy. Polisena (7) states that acute side effects begin around 
the second or third week of radiotherapy, peak two-thirds of the way through 
treatment and last two to three weeks after treatment has ended. For a typical six-week 
course of radiotherapy, one would expect the side effects to be significant between 
five and eight weeks. In this study, dietary intake was found to be negatively 
influenced by the side effects that patients experienced. However, those receiving NI 
had an increase in both kilocalorie and protein intake during the first four weeks 
(when side effects were minimal) and maintained intake for the remainder of the 
study. Intensive and ongoing NI minimised the reduction in dietary intake that 
generally accompanies radiotherapy.  
 
Kilocalorie intake was not different to individual recommendations (Figure 1) for 
each group at baseline, although protein intakes were less than the 1.2-1.5g/kg/d 
recommendations. Ravasco’s study in patients receiving radiotherapy to the head and 
neck found similar results using protein recommendations of 0.8-1g/kg/d (24).  In the 
current study despite the intensity of the NI, the highest protein intake in the NI group 
was 1.3g/kg/d and this was associated with beneficial outcomes compared with the SP 
group. This suggests that for some patients attaining a protein intake of 1.5g/kg/d is 
unrealistic and a more appropriate goal is 1.2g/kg/d or maintenance of baseline 
protein intake.  
 
It has been suggested that treatment side effects such as dry mouth, early satiety, 
fatigue, and anorexia are possible to ameliorate with the appropriate dietary intake and 
individualized suggestions for modifying the diet (28). In a randomized, controlled 
trial (n=75) conducted in patients receiving radiotherapy to the head and neck area, 
increases were observed in both kilocalorie (P≤0.05) and protein intakes (P≤0.006) in 
those subjects receiving dietary counseling with regular foods (n=25) and usual diet 
plus supplements (n=25) compared with the ad lib group (n=25) who experienced a 
decrease in protein and kilocalorie intakes (P<0.01) (24). Both the study performed by 
Ravasco et al (24) and the current study showed increased kilocalorie and protein 
intakes with nutrition intervention compared with SP or an ad lib diet. However in 
Ravasco’s study only those subjects receiving dietary counseling with regular foods 
had maintained their kilocalorie and protein intakes three months after commencing 
radiotherapy and subjects in the other two groups had intakes that returned to or 
below baseline levels. These differences in results may be due to the different lengths 
of nutrition intervention: approximately 7 weeks (24) and 12 weeks for the current 
study (14).  
 
The two patients in the SP group who received enteral nutrition were patients that 
experienced deterioration in oral intake and hence nutritional status. As baseline 
characteristics were not significantly different it appears that the decrease in oral 
intake and decline in nutritional status precipitated the need for enteral nutrition rather 
than reflecting a higher severity of illness. However, a larger study with a more 
homogenous population and stratified by tumor staging and/or symptom severity 
would be required to definitively answer this. 
 
While overall kilocalorie and protein intakes varied between patients receiving NI or 
SP, this is illustrated more clearly when observing daily kilocalorie and protein intake 
per kilogram of body weight. These results are comparable with other studies which 
have shown that patients with cancer require a minimum of 30kcals/kg/day 
(120kJ/kg/day) to maintain weight (29,30). 
 
How does dietary intake relate to other outcomes previously found? 
Subjects receiving NI did significantly better in terms of body weight, nutritional 
status and QoL compared with those receiving SP and full details are presented 
elsewhere (14). The mean kilocalorie intake can account for the differences in body 
weight experienced between the groups (Figure 2). The NI group maintained body 
weight over 12 weeks (mean change = -0.4kg) compared with those receiving SP who 
had a significantly greater deterioration in weight (mean change = -4.7kg) (P<0.001) 
(14). Those receiving NI had a significantly smaller deterioration in nutritional status 
as measured by PG-SGA score (P=0.02), global QoL (P=0.009) and physical function 
(P=0.012) over time compared with the SP group (14). Therefore the differences in 
kilocalorie and protein intake between the NI and SP groups appear to be responsible 
for the maintenance in outcomes in the NI group compared with a decline in those 
receiving SP. 
  
Only two other studies demonstrating an association between dietary intake, 
nutritional status and QoL in patients receiving radiotherapy could be identified in the 
literature (24,31). Ravasco et al (31) demonstrated a correlation between an increase 
in nutrition intake and improvements in nutritional status (P=0.007) and QoL 
(P=0.001) in 125 patients receiving radiotherapy to the gastrointestinal and head and 
neck area. It was also found that QoL improved proportionally with increases in 
kilocalorie and protein intakes (P<0.001) and with improvements in patients’ 
nutritional status (P<0.05) in subjects receiving radiotherapy to the head and neck 
area who were randomized to receive dietary counseling with regular foods (n=25) 
(24). A post hoc analysis in 107 weight-losing patients with unresectable pancreatic 
cancer also demonstrated that weight stabilization was associated with improved 
survival and quality of life (29). 
 
While several studies have shown that enteral feeding prior to commencement of 
radiotherapy is beneficial in terms of maintenance of nutritional status and body 
weight (32-34) until recently there has been little evidence that nutrition counseling is 
beneficial in patients receiving radiotherapy. The current trial (14) and work by 
Ravasco and colleagues (24) are the first studies which demonstrate that nutritional 
counseling in patients receiving radiotherapy is beneficial in terms of improving 
outcomes including dietary intake, nutritional status and QoL. 
 
Evidence-based dietetic practice protocols 
While MNT protocols are developed with evidence that is at hand, it is important that 
protocols are evaluated and updated as new evidence emerges. To our knowledge this 
is the first study in patients receiving radiotherapy to the head and neck or 
gastrointestinal area that has demonstrated that patients receiving NI following the 
ADA MNT radiation oncology protocol has resulted in improved dietary intake, body 
weight, nutritional status and QoL outcomes compared with SP. It is known that 
weekly dietetic counseling during radiotherapy (24,35) and weekly dietetic counseling 
during radiotherapy with follow-ups every 2 weeks for 6-weeks following treatment 
(14) are beneficial in terms of dietary intake, nutritional status and QoL in patients 
receiving radiotherapy to head and neck and/or gastrointestinal area. In a patient 
satisfaction survey conducted in 143 patients receiving radiotherapy, MNT provided 
by a dietitian was perceived as being beneficial and problems that best responded to 
MNT were loss of appetite or weight loss (36). Therefore reviews with the dietitian 
weekly or every two weeks during radiotherapy and follow-up demonstrate improved 
outcomes.  Polisena (37) investigated 72 patients undergoing radiotherapy (mixed 
diagnoses) for the perceived benefits of two MNT visits. While two studies were 
identified in the literature assessing the perceived benefits of MNT in patients 
undergoing radiotherapy (36,37), the current trial is the first study that we are aware 
of that has prospectively assessed the benefits of NI following ADA MNT protocols 
with SP in this population.  
 Study strengths and limitations 
Many NI studies provide insufficient description of what the dietetic counseling 
involved, the frequency of contact and follow-up (28). The suggested reasons why the 
current trial was successful in maintaining outcomes in the NI group compared with 
the SP group is the intensity and frequency of the nutrition counselling by a dietitian 
following the ADA MNT protocol. There was also a substantial follow-up period 
even after completing radiotherapy.  
 
A potential limitation of the study is the accuracy of the dietary intake as assessed by 
the diet history method. Accuracy is a problem for the diet history as it is for all 
methods of dietary assessment (41). However, the diet history by focusing on usual 
intake rather than a few specific days, such as the 24-hour recall or food frequency 
questionnaire, is a major strength of this form of dietary assessment (42). The diet 
history may help to overcome some of the difficulty accounting for the day to day 
variations that may occur with fluctuating symptoms such as pain and nausea (29). 
Although some recall bias by the subjects may have occurred one would expect that 
this would happen evenly between the SP and NI groups. There may also be limited 
generalizability of these findings based on the sample size of 54 subjects.  
 
In conclusion, early and intensive NI following the ADA MNT radiation oncology 
protocol results in improved mean kilocalorie and protein intake compared with SP. It 
also appears to be responsible for the beneficial impacts on nutrition-related outcomes 
such as body weight, nutrition status and QoL previously observed in oncology 
outpatients receiving radiotherapy to the gastrointestinal or head and neck area. It is 
recommended that all patients identified as being malnourished or at risk of 
malnutrition should receive early and ongoing NI by a dietitian to help maintain 
kilocalorie and protein intakes during radiotherapy treatment.  
 
Applications 
The ADA MNT for radiation oncology patients is a useful guide to the level of 
nutrition support required. If insufficient dietetic resources are available it is 
recommended that nutrition screening and triage systems be implemented to ensure 
those clients in most need of care receive a level which demonstrates outcomes. 
Further research is required to investigate the cost versus benefits of having a dietetic 
service to the health care facility. Other outcomes that can be measured to provide 
useful data include mortality and readmission data. Dietetic practice needs to be 
evidence based in order to ensure that resources are most effectively utilized and that 
the patient derives the greatest benefit.  
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Table 1: Baseline characteristics for 60 subjects receiving nutrition intervention 
(NI) and standard practice (SP) 
Variable 
(n) 
NI 
(29) 
SP 
(31) 
Gender (M:F) 24:5 27:4 
Age (years) 60.6 ± 15.6 63.3 ± 12.5 
Weight (kg) 74.8 ± 7.8 77.6 ± 18.2 
BMI (kg/m2) 25.2 ± 4.4 26.4 ± 4.5 
PG-SGA* score 7.1 ± 6.1 5.9 ± 4.3 
PG-SGA* global rating   
     -A (well nourished) 17 (59) 22 (71) 
     -B (suspected or moderately malnourished) 9   (31) 8   (26) 
     -C (severely malnourished) 3   (10) 1   (3) 
Global QoL score 67.7 ± 18.8 75.3 ± 19.2 
                  Continuous variables presented as mean ± SD.  Categorical variables are presented as 
counts (%). 
                           *PG-SGA = Patient Generated-Subjective Global Assessment (13,20) 
                    No statistically significant differences between groups with P>0.05 for all variables
Figure 1: Actual mean kilocalorie and protein intakes compared with estimated requirements 
at baseline  
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Patients’ mean actual Kilocalorie intake and recommended intakes were similar with 
no significant differences between the groups. Actual mean protein intakes were 
significantly lower than recommendations for both Group 1 (P=0.022) and Group 2 
(P=0.002).  
Group 1 = standard practice (n=31) and Group 2 = nutrition intervention (n=29). 
Estimated energy requirements are based on the Harris Benedict equation (18) using 
adjusted weight for underweight and overweight/obese patients as described by (19) 
Estimated protein requirements range from 1.2-1.5g/kg/day.  
 
Table 2: Mean energy, protein and fibre intake for 54 subjects receiving either nutrition 
intervention (NI) or Standard Practice (SP) while undergoing radiotherapy to the 
gastrointestinal or head and neck area. 
 
Outcome Week 0 
Mean (SD) 
Week 4 
Mean (SD) 
Week 8 
Mean (SD) 
Week 12 
Mean (SD) 
P value# 
Energy intake (kcal/day)    NI 
                                              SP 
2104 (509)  
2130 (715) 
 
2320 (496) 
1907 (696) 
2105 (557) 
1801 (593) 
2190 (427) 
1953 (562) 
0.029* 
Energy intake                      NI 
(kcal/kg/day)                        SP 
27.9 (6.8)  
28.5 (9.2) 
31.2 (8.9)  
25.9 (8.3) 
 
28.5 (8.4) 
25.0 (7.4) 
 
29.3 (5.9) 
27.8 (8.0) 
0.022* 
 
Protein intake (g/day)         NI 
                                              SP 
78.9 (21.1) 
82.8 (29.6) 
92.8 (29.6) 
72.7 (31.7) 
 
86.3 (25.4) 
70.3 (28.2) 
82.4 (17.2) 
80.0 (25.3) 
<0.0001* 
Protein intake                      NI 
(g/kg/day)                             SP 
1.1 (0.3) 
1.1 (0.4) 
1.3 (0.5) 
1.0 (0.4) 
1.2 (0.4) 
1.0 (0.4) 
1.1 (0.2) 
1.0 (0.4) 
0.001* 
 
Fiber (g/day)                        NI   
                                              SP       
 
23.7 (7.0) 
24.3 (6.0) 
 
24.7 (6.5) 
21.8 (9.2) 
 
24.0 (6.5) 
22.5 (8.8) 
 
25.8 (5.3) 
22.8 (6.5) 
 
0.083 
 
#Based on repeated measures ANOVA analyses for between-subject effects for the NI 
and SP groups. 
*Statistical significance is reported at P<0.05 two-tailed level. 
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Figure 2: Mean kilocalorie intake and mean body weight for 54 ambulatory radiation 
oncology patients receiving either nutrition intervention (NI) or standard practice (SP) 
1907
1801
1953
2105
2320
2104
2190
2130
76.5
75.8 75.976.3
74.8
73.1
72.2
76.9
1700
1900
2100
2300
Week 0 Week 4 Week 8 Week 12
Time (weeks)
M
ea
n 
K
ilo
ca
lo
rie
 in
ta
ke
 (K
ca
l)
71
72
73
74
75
76
77
78
M
ea
n 
w
ei
gh
t (
kg
)
NI Energy intake SP Energy intake NI Weight SP Weight
 
 29
Table 3: Nutritional status as defined by PG-SGA* global rating for oncology outpatients 
receiving nutritional intervention (NI) or standard practice (SP) 
 
Nutritional status           Week 0 
            (n=60) 
 
     NI             SP 
        Week 4 
         (n=57) 
 
     NI             SP 
        Week 8 
         (n=55) 
 
     NI             SP 
         Week 12 
            (n=54) 
 
       NI                 SP 
Well nourished 
(PG-SGA A) 
17 22 13 9 18 11 19 15 
Malnourished 
(PG-SGA B, C) 
 
12 9 14 21 8 18 6 14 
P value# 
 
                      0.316                       0.160                       0.020                              0.065 
 
*PG-SGA = Patient Generated-Subjective Global Assessment (13,20) 
#Chi square analysis 
 
